Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pathogenic loss-of-function germline TERT mutations in patients with solid tumors
    Journal Article

    Walsh, M. F.; Sacca, R.; Wildman, T.; Amoroso, K.; Kennedy, J.; Zhang, L.; Birsoy, O.; Mandelker, D.; Steinsnyder, Z.; Latham, A.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Predicting expected absolute chemotherapy treatment benefit in women with early-stage breast cancer using EndoPredict, an integrated 12-gene clinicomolecular assay
    Journal Article

    Soliman, H.; Flake, D. D. 2nd; Magliocco, A.; Robson, M.; Schwartzberg, L.; Sharma, P.; Brown, K.; Wehnelt, S.; Kronenwett, R.; Gutin, A.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Controlled and uncontrolled stochastic Norton-Simon-Massagué tumor growth models
    Conference Paper

    Belkhatir, Z.; Pavon, M.; Mathews, J. C.; Pouryahya, M.; Deasy, J. O.; Norton, L.; Tannenbaum, A. R.
    IEEE (2019)

    Fulltext@MSK | Save
  • eIF4A regulates ERK activation by controlling the translation of DUSP6
    Meeting Abstract

    Xu, J.; Wendel, H. G.; Pelletier, J.; Yao, Z.; Rosen, N.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Chandran, S.; Ma, J.; Klatt, M. G.; Dundar, F.; Zumbo, P.; Femia, M. R.; Betel, D.; Scheinberg, D. A.; Baker, B. M.; Klebanoff, C. A.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • NP-G2-044, a novel fascin inhibitor, blocks tumor metastasis and increases antitumor immune response
    Meeting Abstract

    Chung, V.; Tsai, F.; Jhaveri, K.; Wang, Y.; Von Hoff, D. D.; Garmey, E. G.; Zhang, J. J.; Huang, X. Y.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Acupuncture versus cognitive behavioral therapy for insomnia in cancer survivors: A randomized clinical trial
    Journal Article

    Garland, S. N.; Xie, S. X.; DuHamel, K.; Bao, T.; Li, Q.; Barg, F. K.; Song, S.; Kantoff, P.; Gehrman, P.; Mao, J. J.
    JNCI: Journal of the National Cancer Institute (2019)

    Fulltext@MSK | Save
  • Supporting data sharing
    Editorial

    Kirk, R.; Norton, L.
    npj Breast Cancer (2019)

    Fulltext@MSK | Save
  • Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to predict and identify late recurrence, research directions
    Review

    Dowling, R. J. O.; Sparano, J. A.; Goodwin, P. J.; Bidard, F. C.; Cescon, D. W.; Chandarlapaty, S.; Deasy, J. O.; Dowsett, M.; Gray, R. J.; Henry, N. L.; more...
    JNCI Cancer Spectrum (2019)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: Results from the NCI-MATCH trial (EAY131) subprotocol Q
    Journal Article

    Jhaveri, K. L.; Wang, X. V.; Makker, V.; Luoh, S. W.; Mitchell, E. P.; Zwiebel, J. A.; Sharon, E.; Gray, R. J.; Li, S.; McShane, L. M.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save